Published: Dec 08, 2020, 05:29 IST | Updated: Dec 08, 2020, 05:29 IST
An expert committee of the Central Drugs Standard Control Organisation (CDSCO) will meet on Wednesday to review applications of Pfizer, Serum Institute of India and Bharat Biotech.